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Stellingen behorende bij het proefschrift 
An economic assessment of high-dose influenza vaccine 
Estimating the vaccine-preventable burden of disease in the United States using real-world data 
 
1. Vaccination with high-dose instead of standard-dose or adjuvanted influenza vaccines saves 
money. (this thesis) 
2. The more certain we want to be that the use of high-dose influenza vaccine saves money, the 
more we will underestimate the savings. (this thesis) 
3. Quadrivalent high-dose influenza vaccine will prevent more hospitalizations than quadrivalent 
standard-dose or adjuvanted influenza vaccine. 
4. Dutch seniors need to have access to high-dose influenza vaccine. 
5. Effectiveness studies using real-word data profoundly complement randomized clinical trials. 
6. Vaccination is the best strategy to prevent influenza infection. 
7. The disease burden of respiratory syncytial virus (RSV) among infants under one year of age is 
vastly underreported. 
8. The probability of developing a successful Covid-19 vaccine is negatively correlated with the 
probability of hitting the Paris climate agreement goals. 
9. Was mich nicht umbringt, macht mich stärker (Friedrich Nietzsche) 
10. Messieurs, c’est les microbes qui auront le dernier mot. (Louis Pasteur) 
